Alkem Laboratories Limited
ALKEM
Classifica tra le azioni
#2814
Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in... Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in the research, manufacturing, and worldwide distribution of both medicinal and nutritional products. Its comprehensive offerings encompass a variety of branded and generic drugs, active pharmaceutical ingredients (APIs), biosimilars, and nutraceuticals. These products target both immediate and chronic health issues across numerous therapeutic areas, including anti-infectives, skin conditions, cardiovascular health, respiratory ailments, digestive problems, central nervous system disorders, cancer, urology, and women's health. The company also provides essential vitamins, minerals, and nutritional supplements, in addition to pain relief medications, anti-diabetic treatments, and neurological remedies. Complementing its core pharmaceutical lines, Alkem offers consumer health items such as pregnancy detection kits and condoms. Founded in 1973, the company's headquarters are located in Mumbai, India.
Prezzo delle azioni
$55.19
Capitalizzazione di mercato
$6.60B
Variazione (1 giorno)
-0.06%
Variazione (1 anno)
-12.43%
Paese
IN
Scambia Alkem Laboratories Limited (ALKEM)
Categoria
Healthcare
Utile per Alkem Laboratories Limited (ALKEM)
Utile nel Jun 2026 TTM: $316.88M
Secondo gli ultimi rapporti finanziari di Alkem Laboratories Limited, gli utili attuali della società sono $316.88M. Nel 2024, la società ha registrato un utile di $242.63M, un aumento rispetto a agli utili del 2023, che erano di $158.77M. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di Alkem Laboratories Limited dal 2010 al 2026
Utile alla fine di ogni anno
| Anno | Utile | Cambia |
|---|---|---|
| 2026 (TTM) | $316.88M | 7.25% |
| 2025 | $295.47M | 21.78% |
| 2024 | $242.63M | 52.82% |
| 2023 | $158.77M | -34.65% |
| 2022 | $242.96M | -3.45% |
| 2021 | $251.64M | 50.48% |
| 2020 | $167.23M | 21.64% |
| 2019 | $137.48M | -3.33% |
| 2018 | $142.22M | -4.39% |
| 2017 | $148.75M | 6.15% |
| 2016 | $140.14M | 93.97% |
| 2015 | $72.25M | -3.44% |
| 2014 | $74.83M | -20.27% |
| 2013 | $93.85M | 4.73% |
| 2012 | $89.61M | 12.42% |
| 2011 | $79.71M | 46.07% |
| 2010 | $54.57M | 0.00% |
Utile per aziende simili o concorrenti
| Azienda | Utile | Differenza negli utili | Il paese |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | 456.85% |
IN
|
